<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Keeping in view the fact that molecular basis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is poorly understood, we attempted to explore the small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> (siRNA) mediated c-myc gene regulation using <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-derived EB-3 cell line as archetype cellular model </plain></SENT>
<SENT sid="1" pm="."><plain>Such a study revealed that EB-3 cells possess 4-fold higher expression of Dicer gene coupled with 2-fold higher activity of <z:chebi fb="40" ids="33697">RNA</z:chebi> polymerase III than that observed in <z:mpath ids='MPATH_458'>normal</z:mpath> human lymphocytes </plain></SENT>
<SENT sid="2" pm="."><plain>siRNAs derived from EB-3 cells had the inherent capacity to suppress c-myc gene expression in <z:mpath ids='MPATH_458'>normal</z:mpath> cells but not in native cells </plain></SENT>
<SENT sid="3" pm="."><plain>Based on these findings we have proposed a novel <z:chebi fb="40" ids="33697">RNA</z:chebi>-mediated c-myc gene regulation pathway that may be responsible for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>